Viewing Study NCT03292302


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-04-23 @ 9:36 AM
Study NCT ID: NCT03292302
Status: COMPLETED
Last Update Posted: 2023-08-22
First Post: 2017-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of ELX-02 in Healthy Adults
Sponsor: Eloxx Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EL-006
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View